StockData
Phathom Pharmaceuticals, Inc. logo

Phathom Pharmaceuticals, Inc. (PHAT) stock

PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/30
$6.06−0.17 (-2.73%)

Close on Nov 13, 2026Market cap $492.63MP/E –Yield –

Phathom Pharmaceuticals statistics

77 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 25, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$492.63M
$272.32M
Enterprise Value
$473.61M
$146.23M
PS Ratio
1.79
3.68

Enterprise valuationIndustry

EV / Sales
1.72
2.55

Share statisticsIndustry

Shares Change (YoY)
12.3%
10.8%
Shares Change (QoQ)
1.44%
0.50%
Float
71M
49M
Shares Held by Insiders
12.2%
11.7%
Shares Held by Institutions
88.7%
56.4%

Short sellingIndustry

Short Interest
9M
–
Short Interest Change
-5.93%
-0.73%
Short % of Float
12.9%
9.06%
Short % of Shares Outstanding
11.3%
6.30%
Days to Cover
4.83
5.15

Stock price statisticsIndustry

52-Week High
$18.31
–
52-Week Low
$5.01
–
20-Day Moving Average
$6.06
–
50-Day Moving Average
$6.97
–
200-Day Moving Average
$10.03
–
Average True Range (14)
$0.53
–
Price Change (1 Week)
15.4%
-1.15%
Price Change (1 Month)
-19.2%
-4.87%
Price Change (3 Months)
-34.7%
-21.3%
Price Change (6 Months)
-48.9%
-20.8%
Price Change (YTD)
-63.5%
-23.8%
Price Change (1 Year)
-58.5%
-23.0%
Price Change (3 Years)
-14.6%
-29.5%
Price Change (5 Years)
-72.2%
-77.9%
Average Volume (10 Days)
2M
–
Average Volume (20 Days)
2M
–
Average Volume (90 Days)
1M
–
Relative Volume
1.01
0.70
Relative Strength Index (14)
46.6
43.4
Volatility (1 Year)
69.3%
80.2%
Beta (5 Years)
1.63
1.06

MarginsIndustry

Gross Margin
80.7%
53.1%
Operating Margin
-9.26%
-38.7%
Profit Margin
-30.2%
-31.6%
EBITDA Margin
-9.09%
-27.7%
FCF Margin
-7.65%
-9.56%

Returns on capitalIndustry

Return on Assets (ROA)
-28.4%
-40.6%
Return on Capital Employed (ROCE)
-15.0%
-37.9%

Financial positionIndustry

Current Ratio
1.76
3.30
Quick Ratio
1.67
2.39
Interest Coverage
-0.41
-6.35

GrowthIndustry

Revenue Growth (YoY)
86.8%
6.82%

EfficiencyIndustry

Asset Turnover
0.94
0.40
Inventory Turnover
9.45
2.73
Revenue Per Employee
$740.92K
$429.29K
Profits Per Employee
-$223.71K
-$689.41K
Employee Count
371
74
WACC
12.8%
10.1%

Income statement (TTM)Industry

Revenue
$274.88M
$66.37M
Gross Profit
$221.77M
$120.78M
Operating Income
-$25.46M
-$21.37M
Net Income
-$83.00M
-$22.35M
EBITDA
-$24.98M
-$17.21M
EPS (Diluted)
-$1.03
-$0.76

Balance sheetIndustry

Total Debt
$165.54M
$116.91M
Net Cash (Debt)
$19.02M
$17.76M
Net Cash Per Share
$0.23
$0.80
Equity (Book Value)
-$347.64M
$53.89M
Book Value Per Share
-$4.28
$1.50
Tangible Book Value
-$347.64M
$27.13M
Working Capital
$133.11M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$20.74M
-$12.38M
Capital Expenditures
-$302.00K
-$1.00M
Free Cash Flow
-$21.04M
-$18.21M
FCF Per Share
-$0.26
-$0.42

Dividends and yieldsIndustry

Earnings Yield
-16.8%
-21.8%
FCF Yield
-4.27%
-9.44%

Taxes and interestIndustry

Interest Expense
$62.71M
$2.90M

Scores and fair valueIndustry

Altman Z-Score
-4.83
0.22
Piotroski F-Score
4
4
Beneish M-Score
-1.38
-2.63

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodPHATS&P 500DifferencePHAT per yearS&P 500 per year
1 month-13.4%-3.0%−10.4 pts
3 months-34.0%-2.8%−31.2 pts
Year to date-63.5%+11.5%−75.0 pts
1 year-59.2%+13.5%−72.7 pts
3 years-15.2%+77.7%−92.9 pts-5.4%+21.1%
5 years-72.2%+72.6%−144.8 pts-22.6%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

9M PHAT shares were sold short on Oct 30, 2026, down 5.9% from the previous report, or 12.89% of the shares available to trade. At recent volumes it would take 4.8 days to buy them back. Over the last 20 sessions, 46.7% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20269,204,035-5.9%1,903,9504.8
Oct 15, 20269,784,183-3.2%1,411,3006.9
Sep 30, 202610,109,151-0.5%1,373,1847.4
Sep 15, 202610,157,209-6.2%1,114,7239.1
Aug 31, 202610,823,977-8.1%983,43211.0
Aug 14, 202611,773,979-11.7%1,713,9506.9
Jul 31, 202613,327,316+9.9%1,531,4628.7
Jul 15, 202612,121,682+1.1%1,347,5159.0
Jun 30, 202611,993,590+7.4%1,028,05611.7
Jun 15, 202611,162,619+7.8%1,076,98010.4
May 29, 202610,352,426+0.6%1,099,6169.4
May 15, 202610,288,317+5.7%1,185,6088.7

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?